Lucid Diagnostics Inc. ( LUCD) - Key Metrics
LUCD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.01 | -$0.10 | -$0.10 | -$0.10 |
| 2025Q2 | $0.01 | -$0.04 | -$0.11 | -$0.11 |
| 2025Q1 | $0.01 | -$0.39 | -$0.18 | -$0.18 |
LUCD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -2.63 |
| 2025Q2 | ? | -6.41 |
| 2025Q1 | ? | -0.95 |
LUCD
Price: $0.98
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 72027
Market Capitalization: 105.4 million